ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Prognostic significance of cyclinD1 amplification and the co-alteration of cyclinD1/pRb/ppRb in patients with esophageal squamous cell carcinoma

Wang M T; Chen G; An S J; Chen Z H; Huang Z M; Xiao P; Ben X S; Xie Z; Chen S L; Luo D L; Tang J M; Lin J Y; Zhang X C; Wu Y L*广东省人民医院; 汕头大学; x
Diseases of the Esophagus2012-10DOI: 10.1111/j.1442-2050.2011.01291.x
8被引7阅读
引用收藏
分享

摘要

CyclinD1/pRb/ppRb is one of the most important pathways regulating the cell cycle, and related with the development of many cancers. However, the co-alteration of CyclinD1/pRb/ppRb in esophageal squamous cell carcinomas is less understood. This study aims to analyze the combined prognostic significance of cyclinD1 (CCND1) DNA amplification and the co-alteration of CCND1/pRb/ppRB in patients with esophageal squamous cell carcinoma. CCND1 DNA amplification and the protein expression of CCND1, pRb, and ppRb on 100 tumor specimens and 11 normal tissues were detected using real-time quantitative reverse transcription polymerase chain reaction and immunohistochemistry, respectively. Their prognosis significance was analyzed by KaplanMeier method. We found that 41% of the patients had CCND1 DNA amplification, which had a short survival time compared with the patients without CCND1 amplification (25.63 months vs. not reached, P = 0.007). The patients with the co-alternation of CCND1+/pRb/ppRb+ protein expression levels have a poorer overall survival than the others (11.4 vs. 43.4 months, P = 0.001). Cox regression analysis showed that the co-alternation of CCND1/pRb/ppRb and CyclinD1 amplification were the two most independent prognosis factors of patients with esophageal cancer. These findings suggested that CCND1 amplification and co-alternation of CCND1+/pRb/ppRb+ may play a crucial role in the prognostic evaluation of patients with esophageal cancer, and the patients with CCND1+/pRb/ppRb+ have the worst prognosis in all the patients. The results also indicated that the patients with CCND1 amplification or co-alternation of CyclinD1+/pRb/ppRb+ might be the preponderant people for therapy targeting the CCND1/pRb/ppRb pathway in the future.

学科与关键词

关键词
cyclinD1esophageal squamous cell carcinomappRbpRb
相关
加载中…
  • Identification of a Ten-Gene Signature of DNA Damage Response Pathways with Prognostic Value in Esophageal Squamous Cell Carcinoma
    Zhuang, Weitao; Ben, Xiaosong; Zhou, Zihao; Ding, Yu; Tang, Yong; Huang, Shujie; Deng, Cheng; Liao, Yuchen; Zhou, Qiaoxia; Zhao, Jing; Wang, Guoqiang; Xu, Yu; Wen, Xiaofang; Zhang, Yuzi; Cai, Shangli; Chen, Rixin*; Qiao, Guibin*Journal of Oncology, 2021, 2021: 3726058.被引 1
  • PTPRO promoter methylation in peripheral blood DNA of human esophageal squamous cell carcinoma
    Yanjie You; Yuping Chen; Hao Zhang Cancer Research Center; Cancer Hospital of Shantou; Medical College of Shantou University Dept of Integrative Traditional Chinese; Western Medicine; Cancer Hospital of Shantou; Medical College of Shantou University Dept of Thoracic Surgery; Cancer Hospital of Shantou; Medical College of Shantou University Shantou; Guangdong; China2011医学科学前沿论坛第十二届全国肿瘤药理与化疗学术会议.
  • RAD6 Positively Affects Tumorigenesis of Esophageal Squamous Cell Carcinoma by Regulating Histone Ubiquitination of CCNB1
    Deng, Yu; Li, Yujiang; Wu, Tiantong; Chen, Xuyuan; Li, Xiang; Cai, Kaican*; Wu, Xu*BIOLOGICAL PROCEDURES ONLINE, 2022, 24(1): 4.
查看全部 →

发表信息

论文状态
公开发表
期刊
Diseases of the Esophagus
发表日期
2012-10
卷期
第 25 卷, 第 7 期
页码
664-670
DOI
10.1111/j.1442-2050.2011.01291.x
语言
ENGLISH
成果收录
SCI
资助标注
Foundation of Guangdong Science and Technology Department [2006B60101010, 2007A032000002]; Foundation of Guangzhou Science and Technology Department [2007Z2-0081]; Natural and Science Foundation of Guangdong Province [10151008002000007]

作者

  • W

    Wang M T (第一作者)

    guangdong gen hosp · shantou univ

  • C

    Chen G

    guangdong gen hosp

查看全部 14 位作者收起作者
  • A

    An S J

    guangdong gen hosp

  • C

    Chen Z H

    guangdong gen hosp

  • H

    Huang Z M

    guangdong gen hosp

  • X

    Xiao P

    guangdong gen hosp

  • B

    Ben X S

    guangdong gen hosp

  • X

    Xie Z

    guangdong gen hosp

  • C

    Chen S L

    guangdong gen hosp

  • L

    Luo D L

    guangdong gen hosp

  • T

    Tang J M

    guangdong gen hosp

  • L

    Lin J Y

    guangdong gen hosp

  • Z

    Zhang X C

    guangdong gen hosp

  • W

    Wu Y L (通讯)

    guangdong gen hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417